V
Vir Biotechnology, Inc.
VIR · NASDAQ · Healthcare · 1.6B
Price · close
$9.78
+6.19% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.8×
Enterprise value / EBITDAEV/EBITDA
-3.1×
Free cash flow yieldFCF yield
-29.3%
Return on equityROE
-57.2%
Operating margin
-682.7%
Net debt / EBITDAbalance-sheet strength
0.1×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.